Target
Somatostatin receptor type 3
Ligand
BDBM50054480
Substrate
n/a
Meas. Tech.
ChEMBL_1498161 (CHEMBL3583381)
IC50
7.9±n/a nM
Citation
 Shah, SKHe, SGuo, LTruong, QQi, HDu, WLai, ZLiu, JJian, THong, QDobbelaar, PYe, ZSherer, EFeng, ZYu, YWong, FSamuel, KMadiera, MKaranam, BVReddy, VBMitelman, STong, SXChicchi, GGTsao, KLTrusca, DFeng, YWu, MShao, QTrujillo, MEEiermann, GJLi, CPachanski, MFernandez, GNelson, DBunting, PMorissette, PVolksdorf, SKerr, JZhang, BBHoward, ADZhou, YPPasternak, ANargund, RPHagmann, WK Discovery of MK-1421, a Potent, Selective sstr3 Antagonist, as a Development Candidate for Type 2 Diabetes. ACS Med Chem Lett 6:513-7 (2015) [PubMed]  Article 
Target
Name:
Somatostatin receptor type 3
Synonyms:
SOMATOSTATIN SST3 | SS-3-R | SS3-R | SS3R | SSR-28 | SSR3_HUMAN | SSTR3 | Somatostatin receptor type 3 (SSTR3)
Type:
Protein
Mol. Mass.:
45855.97
Organism:
Homo sapiens (Human)
Description:
P32745
Residue:
418
Sequence:
MDMLHPSSVSTTSEPENASSAWPPDATLGNVSAGPSPAGLAVSGVLIPLVYLVVCVVGLLGNSLVIYVVLRHTASPSVTNVYILNLALADELFMLGLPFLAAQNALSYWPFGSLMCRLVMAVDGINQFTSIFCLTVMSVDRYLAVVHPTRSARWRTAPVARTVSAAVWVASAVVVLPVVVFSGVPRGMSTCHMQWPEPAAAWRAGFIIYTAALGFFGPLLVICLCYLLIVVKVRSAGRRVWAPSCQRRRRSERRVTRMVVAVVALFVLCWMPFYVLNIVNVVCPLPEEPAFFGLYFLVVALPYANSCANPILYGFLSYRFKQGFRRVLLRPSRRVRSQEPTVGPPEKTEEEDEEEEDGEESREGGKGKEMNGRVSQITQPGTSGQERPPSRVASKEQQLLPQEASTGEKSSTMRISYL
  
Inhibitor
Name:
BDBM50054480
Synonyms:
CHEMBL3323086
Type:
Small organic molecule
Emp. Form.:
C30H24FN7O2
Mol. Mass.:
533.5557
SMILES:
Cn1cc(cn1)[C@]1(N[C@H](Cc2c1[nH]c1ccccc21)c1nc(c[nH]1)-c1ccc(F)cc1)c1ccc(cn1)C(O)=O |r|
Structure:
Search PDB for entries with ligand similarity: